Laird Norton Wetherby Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$365K	Buy	1,071 +234	+28%	+$71.1K	0.01%	685
2025 Q2	$203K	Buy	+837	New	+$205K	0.01%	877
2022 Q1	–	Sell	-1,482	Closed	-$401K	–	981
2021 Q4	$401K	Buy	1,482 +48	+3%	+$16.2K	0.02%	608
2021 Q3	$520K	Sell	1,434 -49	-3%	-$16K	0.03%	495
2021 Q2	$509K	Buy	1,483 +81	+6%	+$26.8K	0.03%	503
2021 Q1	$488K	Buy	1,402 +191	+16%	+$63.2K	0.04%	441
2020 Q4	$313K	Buy	1,211 +135	+13%	+$37.2K	0.02%	652
2020 Q3	$308K	Buy	+1,076	New	+$253K	0.03%	519

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's ONC Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management increased its BeOne Medicines Ltd (ONC) stake by 28% in Q3 2025, buying an estimated $71.1K and bringing the position to 1,071 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #685.

Laird Norton Wetherby Wealth Management first reported a position in ONC in Q3 2020 and has held it in 8 quarters since. The position peaked at $520K in Q3 2021. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

Laird Norton Wetherby Wealth Management held 1,071 shares of BeOne Medicines Ltd worth $365K as of Q3 2025.
Laird Norton Wetherby Wealth Management bought 234 BeOne Medicines Ltd shares in Q3 2025, an estimated $71.1K.
BeOne Medicines Ltd made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #685 holding.
Laird Norton Wetherby Wealth Management first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 8 quarters since.
Laird Norton Wetherby Wealth Management's BeOne Medicines Ltd position peaked at $520K in Q3 2021.
266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.